Retinoblastoma is a rare eye cancer form in both benign and malignant tumour especially affecting child. Retinoblastoma-1 is a tumour suppressor gene. Functionality of the protein specified in two pockets A (amino acid 394 to 572) and pocket B (amino acid 646 to 792). This binding site is mainly involved in normal function of Retinoblastoma-1 tumour suppressor activity. In the present study we have analyzed antitumour activity for human eye cancer from cyclophosphamide analogs. Totally we selected ten cyclophosphamide analogs and one currently available market drug cyclophosphamide as a reference compounds for molecular docking studies against human eye cancer protein Retinoblastoma-1 and also Absorption Distribution Metabolism Excretion properties of these compounds were carried out by using Qikprop. Among the many cyclophosphamide analogs one of them (Perfosfamide) are showing best glide score and more number of hydrogen bond against human eye cancer protein Retinoblastoma. and it was found to be under acceptable range with predicted ADME properties. From the molecular interaction studies we are concluding that the above mentioned cyclophosphamide analogs Perfosfamide have best anti tumour activity against human eye cancer.
Introduction
Retinoblastoma is a rare eye cancer starting from retina of the eye in early childhood before the age of five years. Incidence 1 in 20, 000 live births. Retinoblastoma-1 regulates transition of cell cycle from G2 phase to S phase of the cell cycle. The Retinoblastoma-1 protein which was located on chromosome 13q14 was first cloned by friend et al in 1986. Rb1 is a nucleo protein and it has a molecular weight of 110kd.The Retinoblastoma-1 composites of 27exons and 4.7 kb transcript spans of 180kb and 928 amino acids. The large intron spans more than 60kb, the smallest intron has 80bp. The complete genome sequencing of the Retinoblastoma-1 gene was reported by Toguchida et al. [1] [2] [3] . The Retinoblastoma-1 protein having two pocket binding sites namely pocket A and pocket B. These binding sites are mainly involved in normal function of Retinoblastoma-1. Some onco proteins mainly bind to the Retinoblastoma-1 binding pocket A (amino acid 394 to 572) and pocket B (amino acid 646 to 792). These binding sites are mainly involved in normal function of Retinoblastoma-1, which causes mutation due to binding at the same site can leads to defect Retinoblastoma-1 function [4] . Rb1 bind to the E2F and form chromatin remodeling protein like histone deacetylase, histone methyltransferases is used to promote cell cycle regulation, DNA replication, DNA repair, G2/M checkpoint activation, differentiation [5] . Retinoblastoma-1 binds with E2F at G0 and G1 phase of the cell cycle. These interactions can leads to promote transcriptional activity. Some viral onco protein bind with binding pocket of Retinoblastoma-1 like SV 40 large T antigen, human papilloma virus E7 protein, adenovirus E and A. This protein defects Rb1tumour suppressor activity and cell cycle [6] . Insertion, deletions, point mutation, germ line mutation, genetic alterations, frame shift, missense mutation are important in the inactivation of Retinoblastoma-1 tumour suppressor activity. Inactivation of Retinoblastoma-1 gene can lead to develop retinoblastoma, sporadic breast, bladder, prostate, small cell lung carcinoma, head and neck cancer, esophagus, pancreatic cancer, melanoma. Inactivation of Retinoblastoma-1 can case approximately 20% -35% of breast cancer. Heterozygosity loss of Rb1 can cause tumor. 40% of Retinoblastoma is caused by hereditary and remaining 60% caused are without familial history [1, 2] .In the current study we have analyzed anti-tumour activity of the compounds from ten cyclophosphamide analogs and one commercially available compound cyclophosphamide as reference compound for in silico docking studies against human eye cancer protein Retinoblastoma-1, ADME properties were carried out for these compounds by using Glide extra precision and Qikprop.
Material and Methods

Crystal Structure Selection for Target Protein Rb1
There are several X-ray crystal structures were available in the Protein Data Bank for Rb1 protein. The better quality of the Retinoblastoma-1 protein structure was identified by using model validation methods PROCHECK and ERRAT [7] . The PROCHECK programs are useful for assessing the quality not only of protein structures in the process of being solved but also of existing structures and of those being modeled on known structures. The PROCHECK suite of programs provides a detailed check on the stereo chemical quality of a given protein structure. The PROCHECK was used to generate Ramachandrans plot and the quality of the structure was computed in terms of % of residues in favorable regions, % of non Proline, Glycine residues etc. The quality of structure was also further accessed by using ERRAT [8] . ERRAT is a protein structure verification algorithm that is especially well-suited for evaluating the progress of crystallographic model building and refinement.
Preparation of Protein Structure
The crystal structure of Retinoblastoma-1 protein (PDB ID: 2R7G), was recovered from the Protein Data Bank [9] . After selected the protein structure, protein preparation wizard of Schrödinger suite has been used to prepare protein structure. All unwanted water molecules were removed from the protein structure, metal are treated and hydrogen atoms were added, all atom force field (OPLS-2005) charges and atom types were assigned. Energy was minimized until the average root mean square deviations of nonhydrogen atoms reached 3.0Å.
Preparation of Cyclophosphamide and Their Analogs
Cyclophosphamide is currently available drug for Retinoblastoma-1. The 3D structures of cyclophosphamide and their ten analogs were obtained from Pubchem database [10] . All these ligands structures was prepared for molecular docking studies using ligprep version 2.3 [11] . The ligand structure energy were minimized, partial atomic charges were computed using the OPLS-2005 force field by using Schrödinger suite. The 2D representation of the cyclophosphamide and their ten analogs were depicted in [ Fig-1 ].
Docking Studies
The prepared protein was further taken into docking studies. The cyclophosphamide and their ten analogs were obtained from Pubchem database. Each ligand is separately docked with structure of the Retinoblastoma-1 protein by using Glide extra precision [12] . The grid was prepared for protein with the exact same center and the size of the bounding box set on 30Å. The grid box enclosed at the centroid of the retinoblastoma receptor. The grid box center -8.8452, -6.9348, and -15.9663 for x, y and z coordinates. The glide algorithm is based on a systematic search of positions, orientation and conformations of the ligand in the receptor binding site using funnel type approach. The cut off extra precision scoring parameters for extra precision docking were set to 0.0 Kcal/mol. The glide score and glide energy were analyzed by using glide extra precision visualizer. 
Docking Complex Analysis
Protein-ligand complex were further taken into Pymol. Pymol is a molecular visualization tool. Pymol viewer to analyze the type of interaction between ligand and protein. To identify the residues located in binding pocket, protein structure were enlarge around the bound ligand. The hydrogen bond interaction and their distance were analyzed were depicted in figure [4] [5] [6] [7] [8] [9] [10] [11] [12] . The glide score, glide energy, number of hydrogen bonds and their distance were reported in [Table-2 ].
ADME Properties Analysis
The Qikprop program was used to predict the ADME properties of the compounds. The predicts both pharmaceutically relevant and physically significant descriptor. The predicted ADME properties such as number of molecular weight, hydrophophic SASA, hydrophilic SASA, number of rotatable bonds, number of hydrogen bond donor and acceptor, log p (octanol/water), log p (octanol/gas), log p (water/gas), log p (hexadecane/gas), log p Caco cell permeability, log pMDCK, serum binding protein, Lipinski's rule of five, percentage of human oral absorption, which is essential for rational drug design.
Results and Discussion
Several crystal structures are available for the Retinoblastoma-1 protein in protein Data Bank. We have analysis structure quality checking by using PROCHECK and ERRAT to identify the structure which is the best one. The results shows the 2R7G crystal structure was good quality for molecular docking studies based on the quality factor and stereochemistry analysis and structure resolution value from PDB among ten Retonoblastoma1 crystal structures. The Ramachandran plot shows most favored region 94.4% residues, in additional allowed region 5.1% residues, in generously allowed region 0.3% residues and in disallowed region 0.2% residues [ Fig-2 ]. The structure resolution value 1.67Å was obtained from Protein Data Bank. The overall quality factor of the protein 98.946 shows in ERRAT plot [ Fig-3 ]. The PROCHECK, ERRAT and structure resolution value were reported in [ The chain A ASN 480 protein molecule of oxygen atom act as hydrogen bond acceptor. The chain C protein molecule of hydrogen atom interacted with oxygen atom of the ligand molecule. The hydrogen atom of the protein molecule act as hydrogen bond donor. The ligand molecule of oxygen atom act as hydrogen bond acceptor with bond length (1.9 Å) [Fig-5 ]. The observed glide score glide energy for 4-s-(hexane-6-01)-sulfidocyclophosphamide was -5.44 and -71.06 kcal/mol respectively.
Protein-ligand Complex Interaction Analysis
Docking of Retinoblastoma-1 with Perfosfamide
Docking of Retinoblastoma-1 with Trofosfamide
Only one hydrogen bond was formed between docked simulations of Retinoblastoma-1 into Trofosfamide. The glide score glide energy was noted for Trofosfamide were -5.20 and -49.38 kcal/mol respectively. The ligand molecule of oxygen atom well interacted with chain A ASN 480 protein molecule of hydrogen with bond length (2.1 Å). The protein molecule of the hydrogen atom act as hydrogen bond donor, oxygen atom of the ligand molecule act as hydrogen bond acceptor [ Fig-6 ]. 
Docking of Retinoblastoma-1 with 4-s-ethnolsulfide-cyclophosphamide
The docked simulation Retinoblastoma-1 into 4-s-ethnolsulfidecyclophosphamide formed only one hydrogen bonds. The glide score, glide energy of complex was observed with -5.09 and -53.42 kcal/mol respectively. The hydrogen atom of the ligand molecule well interacted with side chain oxygen atom of the chain A ASN 522 protein molecule of hydrogen with bond distance (2.1 Å). The oxygen atom of the protein molecule act as hydrogen bond acceptor, the hydrogen atom of the ligand molecule act as hydrogen bond donor [ Fig-7 ].
Docking of Retinoblastoma-1 with Cyclophosphamide
The docked simulation Retinoblastoma-1 into Cyclophosphamide formed two hydrogen bonds with bond distance (2.0 Å, 2.3 Å). The protein molecule of chain C ASN 480 hydrogen atom interacted with oxygen atom of ligand molecule. The protein molecule of hydrogen atom act as hydrogen bond donor, the oxygen atom of the ligand molecule act as hydrogen bond acceptor. The side chain oxygen atom of the protein molecule LEU 521 interacted with hydrogen atom of the ligand molecule. The hydrogen atom of the ligand molecule act as hydrogen bond donor. The side chain oxygen atom of the protein molecule chain C LEU 521act as hydrogen bond acceptor [Fig-8 ]. The glide score and glide energy calculated by glide extra precision for Cyclophosphamide was -5.04and -41.87 kcal/mol respectively. 
Docking of Retinoblastoma-1 with L-Cyclophosphamide
The docked simulation Retinoblastoma-1 into L-Cyclophosphamide formed two hydrogen bonds with bond distance (2.0 Å, 2.3 Å). ed with oxygen atom of ligand molecule. The protein molecule of hydrogen atom act as hydrogen bond donor, the oxygen atom of the ligand molecule act as hydrogen bond acceptor. The side chain oxygen atom of the protein molecule LEU 521 interacted with hydrogen atom of the ligand molecule. The hydrogen atom of the ligand molecule act as hydrogen bond donor. The side chain oxygen atom of the protein molecule chain C LEU 521act as hydrogen bond acceptor [ Fig-9 ].
Docking of Retinoblastoma-1 with D-Cyclophosphamide
The docked simulation Retinoblastoma-1 into D-Cyclophosphamide formed two hydrogen bonds. The calculated glide score was -5.03 kcal/mol Both interaction formed protein molecule of chain C. The hydrogen atom of protein molecule ASN 480 interacted with oxygen atom of ligand molecule with bond length (2.1Å).The protein molecule act as hydrogen bond donor, the ligand molecule act as hydrogen bond acceptor. The hydrogen atom of ligand molecule interacted with side chain protein molecule of LEU 521 with bond distance (2.1Å). The hydrogen atom of the ligand molecule act as hydrogen bond donor. The LEU 521 protein molecule of oxygen atom act as hydrogen bond acceptor [ Fig-10 ]. Three hydrogen bonds were formed between Retinoblastoma-1 and 5-Bromo-Cuclophosphamide. The protein molecule of ASN 480 residues formed two hydrogen bond with bond distance (1.9Å, 2.8Å). The oxygen atom of the ligand molecule well interacted with protein molecule of ASN 480 residues. The ASN 480 residues present in chain A. The oxygen atom of the ligand act as hydrogen bond acceptor. The hydrogen atom of the protein molecule act as hydrogen bond donor. The oxygen atom of the ligand interacted with hydrogen atom of the chain C ASN 480 protein molecule with bond distance (2.1Å) [Fig-11 ]. The glide score of the complex was calculated as _-5.01 kcal/mol.
Docking of Retinoblastoma-1 with Ifosfamide
Docked simulation of Retinoblastoma-1 into Ifosfamide formed three hydrogen bonds. The hydrogen atom of the protein molecule ASN 480 residues interacted with oxygen atom of the ligand with bond length (2.1Å). The hydrogen atom of the protein molecule act as hydrogen bond donor. The oxygen atom of the ligand molecule act as hydrogen bond acceptor. The oxygen atom of the protein molecule ASN 480 residues interacted with hydrogen atom of the ligand molecule with bond distance (2.1Å). The hydrogen atom of the ligand act as hydrogen bond donor, oxygen atom of the protein molecule ASN 480 act as hydrogen bond acceptor. The ASN 480 residues present in chain C. The hydrogen atom of the protein molecule chain A ASN 480 residues interacted with oxygen atom of the ligand with bond distance (2.1Å). The hydrogen atom of the residues ASN 480 act as hydrogen bond donor. The ligand molecule of oxygen atom act as hydrogen bond acceptor [Fig-12 ]. The glide score and glide energy were calculated (-4.80, -36.37). 
Docking of Retinoblastoma-1 with 6-methyl cyclophosphamide
Two hydrogen bonds were identified between Rb1 with 6-methyl cyclophosphamide with distance (2.1Å, 2.1Å). Theoxygen atom of LEY 521 residues interacted with hydrogen atom of the ligand molecule. The oxygen atom of ligand interacted with hydrogen atom of the ASN 522 residues. The hydrogen atom of the ASN 521 act as hydrogen bond donor [Fig-13 ]. This complex was formed with glide score of -4.19 kcal/mol and glide energy of 36.99 kcal/ mol. 
Pharmacokinetics Properties Prediction
We have analyzed 44 physically significant descriptor and pharmaceutically relevant properties of the cyclophosphamide and their ten cyclophosphamide analogs including molecular weight, hydrogen bond donor, hydrogen bond acceptor, log p (octanol/water), log p (octanol/gas), log p (water/gas), log p (hexadecane/gas), log p Caco cell permeability, log pMDCK, serum binding protein, Lipinski's rule of five, percentage of human oral absorption were reported in [Table-3 ]. Lipinski's rule of five is a rule of thump to evaluate drug likeness, or determine if a chemical compound with a certain pharmacological (or) biological activity has properties that would make it a like orally active drug in human, The rule describes molecular properties that are important in the drug is pharmacokinetics in the human body, including its ADME. These compound were further evaluated for their drug-like behavior through analysis of pharmacokinetics parameters required for absorption, distribution, metabolism, excretion (ADME) by using Qikprop. The cyclophosphamide and their ten analogs were in the acceptable range of Lipinski's rule of five, hydrophobic SASA, hydrophilic and partition coefficient (QP log p(octanol/water)), that defines their liphophilic nature and quality these compounds for proper absorption and permeability. While the cell permeability (QPlog pCaco), a key factor governing drug metabolism and its access to biological membranes, ranged from 687 to 6216.QPPMDCK ranges from -3.070 to 10000. Overall, the percentage human oral absorption for the compounds ranged from 74 to 100%. All the pharmacokinetics parameters are within the acceptable range defines for human use, there by indicates their potential use as drug -like molecules.
Conclusion
In the present study molecular interaction studies were performed for ten cyclophosphamide analogs and commercially available drug cyclophosphamide. The following ligand Perfosfamide having better glide score (-6.50) and more number of hydrogen bond interaction good binding affinity with Rb1protein (PDB ID: 2R7G) when compare to the commercially available drug cyclophosphamide and their analogs. From the molecular interaction studies we concluded that the following ligand Perfosfamide could a potential inhibitor for human eye cancer protein Rb1 in human. Table 3 -Predicted ADME properties for cyclophosphamide and their ten analogs
